A Study of QY101 Ointment in Subjects With Plaque Psoriasis
Phase 2
Recruiting
- Conditions
- Psoriasis
- Interventions
- Drug: QY101Placebo/QY101 ointment
- First Posted Date
- 2023-12-14
- Last Posted Date
- 2023-12-19
- Target Recruit Count
- 160
- Registration Number
- NCT06170840
- Locations
- 🇨🇳
Shanghai Skin Disease Hospital, Shanghai, Shanghai, China
A First-in-Human Study of QY211 Gel in Adult Subjects
Phase 1
Recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: 0.8% QY211 Gel or placeboDrug: 1.5% QY211 Gel or placeboDrug: 0.1% QY211 Gel or placeboDrug: 0.3% QY211 Gel or placebo
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Target Recruit Count
- 56
- Registration Number
- NCT05843422
- Locations
- 🇨🇳
Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
Phase 1
Not yet recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: 5mg QY201 tablets or 5mg QY201 placebo,BIDDrug: 2mg QY201 tablets or 2mg QY201 placebo,BIDDrug: 20mg QY201 tablets，BIDDrug: QY201 placebo，BIDDrug: 10mg QY201 tablets，BIDDrug: 10mg QY201 tablets or 10mg QY201 placebo,QDDrug: 10mg QY201 tablets or 10mg QY201 placebo,BIDDrug: 15mg QY201 tablets or 15mg QY201 placebo,BIDDrug: 20mg QY201 tablets or 20mg QY201 placebo,BIDDrug: 5mg QY201 tablets，BID
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2022-09-02
- Target Recruit Count
- 260
- Registration Number
- NCT05525715
A First-in-Human Study of QY101 Ointment in Adult Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- Drug: QY101 ointment or vehicle
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2023-09-25
- Target Recruit Count
- 77
- Registration Number
- NCT05429177
- Locations
- 🇨🇳
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
© Copyright 2025. All Rights Reserved by MedPath